1. Home
  2. OPAL vs QNCX Comparison

OPAL vs QNCX Comparison

Compare OPAL & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OPAL
  • QNCX
  • Stock Information
  • Founded
  • OPAL 1998
  • QNCX 2012
  • Country
  • OPAL United States
  • QNCX United States
  • Employees
  • OPAL N/A
  • QNCX N/A
  • Industry
  • OPAL Natural Gas Distribution
  • QNCX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • OPAL Utilities
  • QNCX Health Care
  • Exchange
  • OPAL Nasdaq
  • QNCX Nasdaq
  • Market Cap
  • OPAL 73.6M
  • QNCX 47.7M
  • IPO Year
  • OPAL N/A
  • QNCX 2019
  • Fundamental
  • Price
  • OPAL $2.42
  • QNCX $1.68
  • Analyst Decision
  • OPAL Hold
  • QNCX Strong Buy
  • Analyst Count
  • OPAL 3
  • QNCX 5
  • Target Price
  • OPAL $3.00
  • QNCX $8.00
  • AVG Volume (30 Days)
  • OPAL 302.5K
  • QNCX 287.5K
  • Earning Date
  • OPAL 08-06-2025
  • QNCX 08-12-2025
  • Dividend Yield
  • OPAL N/A
  • QNCX N/A
  • EPS Growth
  • OPAL N/A
  • QNCX N/A
  • EPS
  • OPAL 0.02
  • QNCX N/A
  • Revenue
  • OPAL $320,427,000.00
  • QNCX N/A
  • Revenue This Year
  • OPAL $22.45
  • QNCX N/A
  • Revenue Next Year
  • OPAL $19.70
  • QNCX N/A
  • P/E Ratio
  • OPAL $122.16
  • QNCX N/A
  • Revenue Growth
  • OPAL 15.22
  • QNCX N/A
  • 52 Week Low
  • OPAL $1.26
  • QNCX $0.51
  • 52 Week High
  • OPAL $4.39
  • QNCX $2.45
  • Technical
  • Relative Strength Index (RSI)
  • OPAL 39.96
  • QNCX 60.55
  • Support Level
  • OPAL $2.44
  • QNCX $1.55
  • Resistance Level
  • OPAL $2.71
  • QNCX $2.05
  • Average True Range (ATR)
  • OPAL 0.14
  • QNCX 0.15
  • MACD
  • OPAL -0.03
  • QNCX 0.00
  • Stochastic Oscillator
  • OPAL 33.72
  • QNCX 40.32

About OPAL OPAL Fuels Inc.

OPAL Fuels Inc is a fully integrated, nationwide leader in the production and distribution of low-carbon intensity renewable natural gas. The company is also engaged in the marketing and distribution of RNG to heavy-duty trucking and other hard-to-de-carbonize industrial sectors. The company designs, develops, constructs, operates, and services Fueling Stations for trucking fleets across the country that use natural gas to displace diesel as their transportation fuel. The company derives revenue from the sale of Renewable Power, design, development, construction, and service of Fueling Stations, and sales of RNG produced by OPAL and third parties as pipeline-quality natural gas.

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.

Share on Social Networks: